AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke ...Middle East

Medscape - News
The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic stroke or TIA, on top of dual antiplatelet therapy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke )

Apple Storegoogle play

Also on site :